Abstract
Treatment with combined pyrimethamine and sulfadiazine prolonged the pre-patent period and shortened the patent period of cyst-induced toxoplasmosis in cats. Oocyst excretion was inhibited in 3 of 4 cats treated intramuscularly with 2 mg/kg body weight pyrimethamine and 100 mg/kg body weight sulfadiazine but not in 4 cats treated with one-half that dosage. Treatment with 2.2 mg/kg body weight pyrimethamine and 132 mg/kg body weight sulfadiazine mixed in cat food did not inhibit oocyst production but prevented antibody formation. No parasites were found upon histological examination of intramuscularly treated cats on days 3, 5, and 7 after infection. Infection with Toxoplasma gondii induced immunity to an oocyst-producing reinfection in both control and treated cats.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The American Journal of Tropical Medicine and Hygiene
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.